首页> 外文OA文献 >Characteristics, treatment patterns, and survival among ALK+ non-small cell lung cancer (NSCLC) patients treated with crizotinib: A chart review study

【2h】

Characteristics, treatment patterns, and survival among ALK+ non-small cell lung cancer (NSCLC) patients treated with crizotinib: A chart review study

机译：克唑替尼治疗的ALK +非小细胞肺癌（NSCLC）患者的特征，治疗模式和生存：图表审查研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

International audience

机译：国际观众

著录项

作者
Cadranel, Jacques; Park, Keunchil; Arrieta, Oscar; Pless, Miklos; Bendaly, Edmond; Patel, Dony; Sasane, Medha; Nosal, Adam; Swallow, Elyse; Galebach, Philip; Kageleiry, Andrew; Stein, Karen; Degun, Ravi; Zhang, Jie;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Characteristics, treatment patterns, and survival among ALK plus non-small cell lung cancer (NSCLC) patients treated with crizotinib: A chart review study [J] . Cadranel Jacques, Park Keunchil, Arrieta Oscar, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2016,第Null期

机译：克唑替尼治疗的ALK加非小细胞肺癌（NSCLC）患者的特征，治疗模式和生存率：图表审查研究
2. Characteristics, treatment patterns, and survival among ALK plus non-small cell lung cancer (NSCLC) patients treated with crizotinib: A chart review study [J] . Cadranel Jacques, Park Keunchil, Arrieta Oscar, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2016,第Null期

机译：用屈服尼治疗的Alk加非小细胞肺癌（NSCLC）患者的特征，治疗模式和生存：图表审查研究
3. P1.01-019 ALK+ Non-Small Cell Lung Cancer Treated with First Line Crizotinib: Patient Characteristics, Treatment Patterns, and Survival [J] . C. Martín, A. Cardona, O. Arrieta, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第11期

机译：P1.01-019 Alk +非小细胞肺癌用第一线屈曲：患者特征，治疗模式和生存
4. IMPROVING PREDICTION OF SURVIVAL USING CT-BASED TUMOR CHARACTERISTICS IN PATIENTS TREATED FOR METASTATIC NON-SMALL CELL LUNG CANCER [C] . WALKER H. LAND JR., ALAN LITWIN, DAN MARGOLIS, Artificial Neural Networks in Engineering Conference . 2010

机译：基于CT基肿瘤特征改善对转移性非小细胞肺癌的患者的肿瘤特征预测
5. Assessing the effectiveness of palliative chemotherapy for non-small cell lung cancer: A phase IV study of patients treated at Ontario's cancer centres [D] . Harrison, Lyndsay Dawn. 2012

机译：评估姑息化疗对非小细胞肺癌的有效性：在安大略省癌症中心接受治疗的患者的IV期研究
6. BMET-18ASSESSING CENTRAL NERVOUS SYSTEM (CNS) RESPONSE TO ALECTINIB IN TWO PHASE II STUDIES OF PRE-TREATED ALK+ NON-SMALL CELL LUNG CANCER (NSCLC): RECIST VERSUS RANO CRITERIA [O] . Sai-Hong Ignatius Ou, Alice Shaw, Leena Gandhi, 2015

机译：BMET-18评估中枢神经系统（CNS）对alectinib的反应在预治疗的Alk +非小细胞肺癌（NSCLC）的第二阶段研究中：抵抗力与RANO标准
7. Characteristics, treatment patterns, and survival among ALK+ non-small cell lung cancer (NSCLC) patients treated with crizotinib: A chart review study [O] . Cadranel, Jacques, Park, Keunchil, Arrieta, Oscar, 2016

机译：克唑替尼治疗的ALK +非小细胞肺癌（NSCLC）患者的特征，治疗方式和生存：图表审查研究

Characteristics, treatment patterns, and survival among ALK+ non-small cell lung cancer (NSCLC) patients treated with crizotinib: A chart review study

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅